Multi-center Clinical Study of Cord Blood Stem Cell Transplantation for IBD Caused by IL-10R Gene Deficiency
NCT04170192 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2020-02-17
Summary
Very early onset inflammatory bowel disease (VEO-IBD) is a special subtype of children's inflammatory bowel disease (IBD). VEO-IBD is mostly caused by single-gene defects and can be cured by allo-hematopoietic stem cell transplantation ( HSCT). Umbilical Cord Blood Transplantation (UCBT) is less reported in these patients.
Conditions
- Inflammatory Bowel Diseases
Interventions
- PROCEDURE
-
Cord Blood Stem Cell Transplantation
Unrelated cord blood stem cell selection; Reduced intensity conditioning regime; GVHD prevention; Infection prevention.
Sponsors & Collaborators
-
Shanghai Children's Hospital
collaborator OTHER -
Children's Hospital of Soochow University
collaborator OTHER -
Beijing Children's Hospital
collaborator OTHER -
Guangzhou Women and Children's Medical Center
collaborator OTHER -
Shenzhen Children's Hospital
collaborator OTHER_GOV -
Wuhan Women and Children's Medical Center
collaborator OTHER -
Children's Hospital of Nanjing Medical University
collaborator OTHER -
The First Affiliated Hospital of Zhengzhou University
collaborator OTHER -
Children's Hospital of Fudan University
lead OTHER
Principal Investigators
-
Jiang Hui, Master · Shanghai Children's Hospital
-
Hu Shaoyan, PHD · Children's Hospital of Soochow University
-
Qin Maoquan, PHD · Beijing Children's Hospital
-
Jiang Hua, PHD · Guangzhou Women and Children's Medical Center
-
Liu Sixi, Master · Shenzhen Children's Hospital
-
Xiong Hao, PHD · Wuhan Women and Children's Medical Center
-
Fang Yongjun, PHD · Children's Hospital of Nanjing Medical University
-
Wang Dao, PHD · The First Affiliated Hospital of Zhengzhou University
Eligibility
- Min Age
- 1 Month
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-01
- Primary Completion
- 2022-10-31
- Completion
- 2023-10-31
Countries
- China
Study Locations
More Related Trials
-
Ontogeny of MAIT Cells in Neonates and Hematopoietic Stem Cell Transplant Recipients
NCT02403089 ·Status: COMPLETED
-
FMT for Steroid Resistant Gut Acute GVHD
NCT04285424 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia
NCT06729320 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia
NCT05335226 ·Status: UNKNOWN ·Phase: NA
-
Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure
NCT01763099 ·Status: UNKNOWN ·Phase: PHASE2
-
Gene Therapy for X Linked Severe Combined Immunodeficiency
NCT04286815 ·Status: UNKNOWN ·Phase: NA
-
Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).
NCT05664113 ·Status: RECRUITING ·Phase: PHASE1
-
Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease
NCT05152160 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Application of Novel Identified CD8 Regulatory Precursors in Inducing Immune Tolerance After Allo-HSCT
NCT06864598 ·Status: ENROLLING_BY_INVITATION
-
Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA
NCT07299123 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort
NCT05170347 ·Status: RECRUITING
-
Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD
NCT02406651 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders
NCT00897260 ·Status: COMPLETED ·Phase: NA
-
Tube Feeding in Children Having a Bone Marrow Transplant
NCT04804631 ·Status: COMPLETED
-
Unrelated Donor Transplant for Malignant and Non-Malignant Disorders
NCT01050439 ·Status: TERMINATED ·Phase: PHASE2
-
Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders
NCT00744692 ·Status: COMPLETED ·Phase: PHASE1
-
Transplantation of Ex-vivo Expanded Cord Blood Stems Cells
NCT01034449 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT
NCT06362967 ·Status: RECRUITING ·Phase: PHASE2
-
Alterations in Intestinal Microbiota, Metabolites, and Immune Cells in Allo-HSCT
NCT06143501 ·Status: RECRUITING
-
Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant
NCT02668315 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT
NCT07047456 ·Status: RECRUITING ·Phase: PHASE3
-
A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders
NCT00596999 ·Status: UNKNOWN
-
Cord Blood Stem Cell Transplantation Study (COBLT)
NCT00000603 ·Status: COMPLETED ·Phase: PHASE2
-
Cell Therapy in Failure Syndromes in Limbal Stem Cells
NCT01619189 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCT
NCT06423131 ·Status: RECRUITING ·Phase: NA